Thomas Hach, MD, is Executive Director Patient Engagement for Cardiovascular, Renal & Metabolism (CRM) at Novartis. He is leading end-to-end patient engagement strategy and operations for the broad CRM portfolio at Novartis. Thomas also held positions of Global Brand Medical Director Neuroscience, Senior Global Health Advisor and Director Healthcare Systems. His passion and expertise are in precision medicine, patient centricity and partnerships. He joined Novartis from Boehringer Ingelheim, where he was Global Senior Medical Director, Therapeutic Area Metabolism. Prior to that, he was an associate principal at McKinsey & Company, serving as a leader in the pharmaceuticals and healthcare practice. Dr. Hach conducted several years of research and clinical practice in diabetes/microcirculation at Karolinska Institutet, Sweden. At the beginning of his clinical career he worked in orthopedic surgery in Sweden and Germany. He received his medical degree from University of Mainz, Germany.